Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) saw a significant increase in short interest in April. As of April 15th, there was short interest totaling 21,996 shares, an increase of 142.2% from the March 31st total of 9,083 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average trading volume of 13,019 shares, the short-interest ratio is currently 1.7 days.
Wall Street Analyst Weigh In
Separately, Zacks Research raised shares of Raia Drogasil to a “hold” rating in a research report on Thursday, April 9th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.
View Our Latest Stock Report on Raia Drogasil
Raia Drogasil Stock Up 4.5%
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Featured Articles
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
